Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease

StatusUnknown
PhasePhase 2
Started

Record status This record was last updated October 2, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a study to evaluate the effect of pemafibrate on fatty liver in patients with hypertgemia combined with NAFLD, using fenofibrate as a control.
Trial Details
NCT Number NCT06623539
Lead Sponsor Yokohama City University
Conditions
(from sponsor)		 Non Alcoholic Fatty Liver Disease
Related terms Non-alcoholic Fatty Liver Disease
Enrollment 360 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov